300 related articles for article (PubMed ID: 19596861)
1. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.
Smirnovas V; Kim JI; Lu X; Atarashi R; Caughey B; Surewicz WK
J Biol Chem; 2009 Sep; 284(36):24233-41. PubMed ID: 19596861
[TBL] [Abstract][Full Text] [Related]
2. Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates.
Groveman BR; Raymond GJ; Campbell KJ; Race B; Raymond LD; Hughson AG; Orrú CD; Kraus A; Phillips K; Caughey B
PLoS Pathog; 2017 Sep; 13(9):e1006623. PubMed ID: 28910420
[TBL] [Abstract][Full Text] [Related]
3. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
[TBL] [Abstract][Full Text] [Related]
4. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
[TBL] [Abstract][Full Text] [Related]
5. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
[TBL] [Abstract][Full Text] [Related]
6. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
7. Conformational stability of mammalian prion protein amyloid fibrils is dictated by a packing polymorphism within the core region.
Cobb NJ; Apostol MI; Chen S; Smirnovas V; Surewicz WK
J Biol Chem; 2014 Jan; 289(5):2643-50. PubMed ID: 24338015
[TBL] [Abstract][Full Text] [Related]
8. Structural conservation of prion strain specificities in recombinant prion protein fibrils in real-time quaking-induced conversion.
Sano K; Atarashi R; Nishida N
Prion; 2015; 9(4):237-43. PubMed ID: 26284507
[TBL] [Abstract][Full Text] [Related]
9. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
10. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.
Atarashi R; Moore RA; Sim VL; Hughson AG; Dorward DW; Onwubiko HA; Priola SA; Caughey B
Nat Methods; 2007 Aug; 4(8):645-50. PubMed ID: 17643109
[TBL] [Abstract][Full Text] [Related]
12. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient protein misfolding cyclic amplification.
Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
[TBL] [Abstract][Full Text] [Related]
14. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
15. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
[TBL] [Abstract][Full Text] [Related]
16. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
[TBL] [Abstract][Full Text] [Related]
17. Cell Biology Approaches to Studying Prion Diseases.
Priola SA
Methods Mol Biol; 2017; 1658():83-94. PubMed ID: 28861784
[TBL] [Abstract][Full Text] [Related]
18. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.
Tzaban S; Friedlander G; Schonberger O; Horonchik L; Yedidia Y; Shaked G; Gabizon R; Taraboulos A
Biochemistry; 2002 Oct; 41(42):12868-75. PubMed ID: 12379130
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
20. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]